SARAH ALLES: Open Payments
NPI 1912430521 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 29 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $269 |
| Amgen Inc. | 2 | $118 |
| ABBVIE INC. | 6 | $106 |
| Astellas Pharma US Inc | 3 | $95 |
| PFIZER INC. | 4 | $92 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
Products named: EVENITY, Veozah, UBRELVY, NURTEC ODT, QULIPTA, PAXLOVID, INSPIRE, XIFAXAN.
Industry payments across NY — which companies pay providers there.
